YESINTEK conc perf 130 mg/26ml flac

7680703290019 CH-70329 L04AC05 07.15.0.

Active substances:

No images available

Details

Product number
7032901
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, methioninum, dinatrii edetas, saccharum, polysorbatum 80, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 26 ml, natrium 0.007 mmol.

Articles (1)

Yesintek 130 mg / 26 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/07/2026
Professional SmPC
Français
01/07/2026
Professional SmPC
Italien
01/07/2026

Detailed composition

Substance Quantity Type Category
ustekinumabum
130.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
methioninum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.007 MMOL Substance HBESI

Reimbursement information

Public price
CHF 1252.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2026

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70329
Drug name
Yesintek, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L04AC05
Authorization status
Z
Dispensation category
B
First authorization
10/02/2026
Authorization expiration date
09/02/2031
IT number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn

Packaging details

Description (FR)
YESINTEK conc perf 130 mg/26ml flac
Description (DE)
YESINTEK Inf Konz 130 mg/26ml Durchstf
Market launch
01/07/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data